シンポジウム02‐5 アカデミア発の創薬・治療研究 成人型シトルリン血症の治療‐低炭水化物食と経口ピルビン酸投与の有効性

書誌事項

タイトル別名
  • Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate
公開日
2010
DOI
  • 10.5692/clinicalneurol.50.844
公開者
日本神経学会

この論文をさがす

説明

Adult-onset type II citrullinemia (CTLN2) is an autosomal recessive disease characterized by highly elevated plasma levels of citrulline and ammonia due to the urea cycle dysfunction associated with citrin deficiency. Patients with CTLN2 show various neurological symptoms with hyperammonemia closely resembling those of hepatic encephalopathy. Since 1990, 26 CTLN2 patients (17 males and 9 females) have been admitted and treated at Shinshu University Hospital. Twelve of the 26 patients received living related partial liver transplantation (LRLT). After LRLT, neurological symptoms soon disappeared, and all patients returned to their previous social lives. Among the 14 patients that did not undergo LRLT, 6 died of intractable encephalopathy or the development of hepatic cancer, but 8 patients have had relatively good clinical courses (follow-up range 0.5-8 years) with oral intake of L-arginine and low-carbohydrate and relatively protein-rich diet. Six patients have been also given sodium pyruvate and the frequency of attacks of encephalopathy markedly decreased in 5 of 6 patients. Our observations indicated that liver transplantation is a very promising type of therapy but that other therapeutic approaches, including low-carbohydrate diet and pyruvate, are being established.<br>

収録刊行物

  • 臨床神経学

    臨床神経学 50 (11), 844-847, 2010

    日本神経学会

被引用文献 (7)*注記

もっと見る

参考文献 (10)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390282680011414784
  • NII論文ID
    130004504652
  • DOI
    10.5692/clinicalneurol.50.844
  • COI
    1:STN:280:DC%2BC3MfktVaktg%3D%3D
  • ISSN
    18820654
    0009918X
  • PubMed
    21921468
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
    • OpenAIRE
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ